Vaccination represents one of the most effective means of preventing infectious disease. In order to maximize the utility of vaccines, highly potent formulations that are easy to administer and promote high patient compliance are desired. In the present work, a biomimetic self-propelling micromotor formulation is developed for use as an oral antivirulence vaccine. The propulsion is provided by a magnesium-based core, and a biomimetic cell membrane coating is used to detain and neutralize a toxic antigenic payload. The resulting motor toxoids leverage their propulsion properties in order to more effectively elicit mucosal immune responses. After demonstrating the successful fabrication of the motor toxoids, their uptake properties are shown in vitro. When delivered to mice via an oral route, it is then confirmed that the propulsion greatly improves retention and uptake of the antigenic material in the small intestine in vivo. Ultimately, this translates into markedly elevated generation of antibody titers against a model toxin. This work provides a proof-of-concept highlighting the benefits of active oral delivery for vaccine development, opening the door for a new set of applications, in which biomimetic motor technology can provide significant benefits.
Biomimetic Micromotor Enables Active Delivery of Antigens for Oral Vaccination.
Xiaoli Wei,M. Beltrán‐Gastélum,Emil Karshalev,B. Esteban‐Fernandez de Avila,Jiarong Zhou,Danni Ran,Pavimol Angsantikul,Ronnie H. Fang,Joseph Wang,Liangfang Zhang
Published 2019 in Nano letters (Print)
ABSTRACT
PUBLICATION RECORD
- Publication year
2019
- Venue
Nano letters (Print)
- Publication date
2019-02-06
- Fields of study
Medicine, Engineering
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-50 of 50 references · Page 1 of 1